# Study of a Pandemic Influenza Vaccine in Elderly Participants

> **NCT00376402** · PHASE2 · COMPLETED · sponsor: **Seqirus** · enrollment: 200 (—)

## Conditions studied

- Influenza

## Interventions

- **BIOLOGICAL:** H5N1 Pandemic Influenza Vaccine

## Key facts

- **NCT ID:** NCT00376402
- **Lead sponsor:** Seqirus
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2006-10
- **Primary completion:** —
- **Final completion:** 2007-06
- **Target enrollment:** 200 (—)
- **Last updated:** 2016-07-19


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00376402

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00376402, "Study of a Pandemic Influenza Vaccine in Elderly Participants". Retrieved via AI Analytics 2026-06-16 from https://api.ai-analytics.org/clinical/NCT00376402. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*